Hempalta (CVE:HEMP) Trading Up 63.6% – Still a Buy?
Hempalta Corp. (CVE:HEMP – Get Free Report) rose 63.6% during mid-day trading on Tuesday . The stock traded as high as C$0.10 and last traded at C$0.09. Approximately 120,000 shares were traded during trading, a decline of 62% from the average daily volume of 315,525 shares. The stock had previously closed at C$0.06. Hempalta Trading […]
More Stories
Analyzing InterRent Real Estate Investment Trust (OTCMKTS:IIPZF) and Dynex Capital (NYSE:DX)
InterRent Real Estate Investment Trust (OTCMKTS:IIPZF – Get Free Report) and Dynex Capital (NYSE:DX – Get Free Report) are both...
Profire Energy (NASDAQ:PFIE) & Innovex International (NYSE:INVX) Head to Head Survey
Innovex International (NYSE:INVX – Get Free Report) and Profire Energy (NASDAQ:PFIE – Get Free Report) are both small-cap oils/energy companies,...
Vornado Realty Trust (NYSE:VNO) Rating Increased to Outperform at Mizuho
Mizuho upgraded shares of Vornado Realty Trust (NYSE:VNO – Free Report) from a neutral rating to an outperform rating in...
Toyota Motor (NYSE:TM) Upgraded to “Hold” at StockNews.com
StockNews.com upgraded shares of Toyota Motor (NYSE:TM – Free Report) from a sell rating to a hold rating in a...
Janone (NASDAQ:ALTS) and Connect Biopharma (NASDAQ:CNTB) Head-To-Head Review
Janone (NASDAQ:ALTS – Get Free Report) and Connect Biopharma (NASDAQ:CNTB – Get Free Report) are both small-cap finance companies, but...
Oragenics (NYSE:OGEN) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Free Report) in a research note published on Tuesday. The firm...